Wellgistics Health Approves Reverse Stock Split to Avoid Nasdaq Delisting
summarizeSummary
Wellgistics Health's Board and majority shareholders have approved a reverse stock split, with a ratio between 1-for-25 and 1-for-200, to regain compliance with Nasdaq's minimum bid price requirement and prevent delisting.
check_boxKey Events
-
Reverse Stock Split Approved
The Board of Directors and holders of 55.32% of the voting stock approved an amendment to the Certificate of Incorporation to authorize a reverse stock split.
-
Flexible Split Ratio
The Board has discretionary authority for 12 months to implement a reverse split with a ratio between 1-for-25 and 1-for-200.
-
Addresses Nasdaq Delisting Threat
The primary purpose of the reverse split is to regain compliance with Nasdaq's $1.00 minimum bid price requirement, following a delisting notice received on December 10, 2025.
-
No Change to Authorized Shares
The reverse split will not change the total number of authorized shares (500,000,000), but will significantly reduce outstanding shares.
auto_awesomeAnalysis
This PRE 14C filing reveals that Wellgistics Health's Board and majority shareholders have approved a reverse stock split, a critical defensive maneuver to address the Nasdaq minimum bid price requirement. This action directly follows the company's recent 10-K filing on March 20, 2026, which disclosed a Nasdaq delisting notice and a going concern warning. The wide potential split ratio (1-for-25 to 1-for-200) highlights the severity of the company's low stock price and the urgent need to boost it to maintain its listing. While intended to prevent delisting and attract institutional investors, reverse splits often signal underlying financial distress and do not guarantee a sustained increase in stock price or improved liquidity. Investors should be aware of the significant risks, including potential for further price erosion, increased transaction costs for odd lots, and the heightened risk of immediate delisting under new Nasdaq rules if the bid price falls again after the split.
At the time of this filing, WGRX was trading at $0.12 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $12.2M. The 52-week trading range was $0.11 to $7.04. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.